Yahoo Web Search

Sign In
  1. Explore more companies

Search results

  1. Vertex Pharmaceuticals - Local Result

  2. www.vrtx.comVertex Pharmaceuticals | Home

    Vertex Pharmaceuticals | Home. At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases. Read More. News. Jennifer Schneider elected to Vertex Board of Directors. Learn more. Vertex reports first quarter 2024 financial results. Learn More.

  3. 451.64
    Add to watchlist
    +4.11 (+0.92%)
    As of Thu. May 23, 2024 11:37 AM EDT · Nasdaq Real Time Price (USD) · Market open
    Full chart
    • Open
      449.84
      High
      451.99
      Low
      446.67
    • Mkt Cap
      116.55B
      P/E (TTM)
      29.33
      Div & Yield
      N/A & N/A
    • Prev. Close
      447.53
      52 Wk. Low
      320.01
      52 Wk. High
      451.99

    More about VRTX

    What analysts are saying
    Morningstar Bearish Published May 07 · Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases.... Read more
    Top stories

    Related stocks

    More on Yahoo Finance

  4. en.wikipedia.org › wiki › Vertex_PharmaceuticalsVertex Pharmaceuticals - Wikipedia

    Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.

  5. www.vrtx.com › our-companyVertex Pharmaceuticals | Our Company

    In 2023, we ranked #12 in the Mega Employer category. Vertex Pharmaceuticals strikes at the core of serious diseases to change people's lives – learn about our mission, values and recognition.

  6. finance.yahoo.com › quote › VRTXVertex Pharmaceuticals Incorporated (VRTX) - Yahoo Finance

    Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases.

  7. news.vrtx.com › news-releases › news-release-detailsVertex and CRISPR Therapeutics Announce US FDA Approval of ...

    Dec 8, 2023 · BOSTON & ZUG, Switzerland -- (BUSINESS WIRE)--Dec. 8, 2023-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) announced today that the U.S. Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 genome-edited cell therapy, for the treatment of ...

  8. investors.vrtx.com › news-releases › news-releaseVertex Announces Positive Results From the VX-548 Phase 3 ...

    Jan 30, 2024 · BOSTON -- (BUSINESS WIRE)--Jan. 30, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced positive results from its Phase 3 program for the selective NaV1.8 inhibitor, VX-548, in the treatment of moderate-to-severe acute pain.

  9. news.vrtx.com › news-releases › news-release-detailsVertex Presents Positive, Updated VX-880 Results From Ongoing ...

    BOSTON -- (BUSINESS WIRE)--Oct. 3, 2023-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today presented longer-term data on patients dosed in Parts A and B of its Phase 1/2 clinical trial of VX-880, an investigational stem cell-derived, fully differentiated islet cell therapy in people with type 1 diabetes (T1D) with impaired hypoglycemic a...

  1. Searches related to Vertex Pharmaceuticals

    vertex pharmaceuticals stockvertex nyt
    vertex pharmaceuticals diabetes trialvertex new york times
    vertex pharmaceuticals addressvertex
    vertex pharmaceuticals careersvertex pharmaceuticals pipeline
  2. People also search for